Please assess the completion status of the following clinical trial:

Trial Title: Rhinogenic Headache Improvement After Nasal Operation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic (\> 2 months) pain or pressure over nasal bridge, glabella, or forehead~* Unilateral or bilateral nasal septal deviation that is chronically symptomatic (e.g. nasal airway obstruction)~* Failure of standard medical therapy for headache~* Symptomatic contact points as demonstrated by physical examination, sinus CT and nasal endoscopy~* Relief of headache after application of topical anesthetic to contact points~* Contact points that remain after mucosal decongestion~* Absence of any other obvious cause of headaches after a thorough evaluation by a neurologist, ophthalmologist, dentist, internist, or other related specialist~Exclusion Criteria:~* Previous sinonasal surgery~* Active acute sinonasal disease:~  1. Seasonal allergic exacerbations with mucosal swelling~ 2. Acute infectious rhino-sinusitis~* Chronic sinonasal problems:~  1. Severe nasal polyps mimicking contact points~ 2. Mucoceles protruding from sinuses into nasal cavity~ 3. Nasal and sinus tumors~* General medical condition that precludes elective surgery (including pregnancy)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Septoplasty (Type: PLACEBO_COMPARATOR): Septoplasty only
- Septoplasty and correction (Type: EXPERIMENTAL): Septoplasty and endoscopic contact point correction

Based on this trial design, predict the completion outcome and termination type (if applicable).